Provenge helps in fighting prostate cancer
Tuesday, May 5, 2009 - 10:49
in Health & Medicine
SEATTLE, May 5 (UPI) -- U.S. scientists have determined sipuleucel-T, a prostate cancer immunotherapy drug, significantly prolongs survival in men with advanced prostate cancer.